课题基金 / 基金详情

Training Program in Personalized Cardiovascular Medicine (TPIPCVM)

Training Program in Personalized Cardiovascular Medicine (TPIPCVM)
个性化心血管医学培训计划 (TPIPCVM)
批准号:
10454147
负责人:
Dawood Darbar
金额:
$40.29万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-01 至 2024-06-30

项目摘要

项目成果

Dawood Darbar的其他基金

相似基金

相关文献

中文摘要
翻译
个性化心血管医学培训(TPIPCVM) 项目摘要 心血管疾病(CVD)仍然是老年人中显著发病率和死亡率的主要原因。 美国特别是在风险因素负担很高的少数民族中。个性化医疗是一种 快速增长的医疗保健领域,其中个人独特的基因组,环境和临床 分析背景以确定对疾病的易感性,预测其临床过程, 具体治疗。尽管最近在CV基因组学方面取得了进展,但我们无法将治疗靶向 个体患者的潜在机制,未能将这些科学发现转化为 患者的床边护理和少数民族纳入翻译简历的障碍 研究限制了我们实现个性化医疗承诺的能力。此外,委员会认为, 传统的培训计划不再能够为学员提供必要的技能, 实施正在进行的个性化医疗革命。因此,培训的主要目标 个性化心血管医学计划(TPIPCVM)旨在使学员成为 CV基因组学的领导者,并接受分子,细胞,疾病和整体动物建模方面的培训 以及CVD的临床和转化方法,以便将这些新知识转化为 最佳循证个性化CV护理。我们将招募高素质和积极性的前, 博士后培训生,并为他们提供CV基因组学方面的最高水平培训 从我们的教师在心脏病学部门和我们的合作伙伴在UIC现有的优势。的3 研究重点:1)心律失常; 2)缺血性和非缺血性心肌病;和 心血管病相关代谢综合征相互之间高度相关,与心血管疾病的发生、发展直接相关。 个性化CV基因组学的中心主题。TPIPCVM的首要目标是培训 下一代简历研究人员将创造新知识并实施到最佳循证研究中 个性化医疗TPIPCVM导师是非常成功的医生科学家/科学家 与研究,指导和合作谁提供一流的内部和多方面的证明记录, 纪律培训机会。该培训计划的主要优势包括: 学员的综合基础科学分子,细胞和整个病人的方法,以确定 CVD的基本机制;教师的跟踪记录和他们的共同研究兴趣, 个性化CV基因组学;个性化CV医学的专门培训;以及 将科学发现应用于在医院接受治疗的多样化和代表性不足的患者群体, UIC医疗中心TPIPCVM着手培养2名博士前和2名博士后学生 每年。总的来说,这个培训计划提供了一个独特的培训经验,并满足了迫切的需求。 需要个性化CV医学培训。
英文摘要
TRAINING IN PERSONALIZED CARDIOVASCULAR MEDICINE (TPIPCVM) Project Summary Cardiovascular disease (CVD) remains a major cause for significant morbidity and mortality in the U.S. especially in ethnic minorities with their high burden of risk factors. Personalized medicine is a rapidly growing field of healthcare whereby an individual's unique genomic, environmental and clinical background is analyzed to ascertain susceptibility to disease, predict their clinical course and tailor specific therapies. Despite recent advances in CV genomics, our inability to target therapy to underlying mechanisms in individual patients, the failure to translate these scientific discoveries to the bedside care of patients and barriers to the incorporation of ethnic minorities in translational CV research have limited our ability to fulfill the promise of personalized medicine. Furthermore, traditional training programs are no longer able to provide trainees with the requisite skills needed to implement the personalized medicine revolution underway. Thereby, major goals of the Training Program in Personalized Cardiovascular Medicine (TPIPCVM) are to equip trainees to become leaders in CV Genomics and be trained in molecular, cellular, disease and whole animal modeling and clinical and translational approaches to CVD so that this new knowledge can be translated into best evidence-based personalized CV care. We will recruit highly talented and motivated pre- and post-doctoral trainees and provide them with the highest caliber training in CV genomics stemming from existing strengths of our faculty in the Division of Cardiology and our partners at UIC. The 3 Research Focus Groups: 1) Cardiac arrhythmias; 2) Ischemic and non-ischemic cardiomyopathy; and CVD-related metabolic syndrome are highly interrelated with each other and directly linked with the central theme of Personalized CV Genomics. The overarching goal of the TPIPCVM is to train the next generation of CV investigators to create new knowledge and implement into best evidence-based personalized medicine. The TPIPCVM mentors are highly successful physician-scientists/scientists with a proven record of research, mentoring and collaboration who offer superb inter- and multi- disciplinary training opportunities. Major strengths of this training program include: exposure of trainees to an integrated basic science molecular, cellular, and whole patient approach to identify the underlying mechanisms of CVD; the track record of the faculty and their common research interest in Personalized CV Genomics; dedicated training in personalized CV medicine; and the potential to implement scientific discoveries to a diverse and under-represented population of patients cared for at UIC Medical Center. The TPIPCVM sets out to train 2 pre-doctoral and 2 post-doctoral students annually. Collectively, this Training Program offers a unique training experience and fulfills an urgent need for training in personalized CV medicine.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pone.0291598
发表时间: 2023
期刊: PloS one
影响因子: 3.7
作者: []
通讯作者:
DOI: 10.1084/jem.20221388
发表时间: 2023-11-06
期刊: The Journal of experimental medicine
影响因子: --
作者: []
通讯作者:
DOI: 10.1172/jci.insight.155640
发表时间: 2022-04-08
期刊: JCI INSIGHT
影响因子: 8
作者: [Ly, Olivia T., Chen, Hanna, Brown, Grace E., Hong, Liang, Wang, Xinge, Han, Yong Duk, Pavel, Mahmud Arif, Sridhar, Arvind, Maienschein-Cline, Mark, Chalazan, Brandon, Ong, Sang-Ging, Abdelhady, Khaled, Massad, Malek, Rizkallah, Lona Ernst, Rehman, Jalees, Khetani, Salman R., Darbar, Dawood]
通讯作者: Darbar, Dawood
Coronary arterial vasculature in the pathophysiology of hypertrophic cardiomyopathy.
肥厚性心肌病的病理生理学中的冠状动脉血管。
DOI: 10.1007/s00424-018-2224-y
发表时间: 2019-05
期刊: Pflugers Archiv : European journal of physiology
影响因子: --
作者: [Marszalek RJ, John Solaro R, Wolska BM]
通讯作者: Wolska BM
共 11 条
    Genotype-guided therapy for atrial fibrillation
    Genotype-guided therapy for atrial fibrillation
    Human iPSC-derived atrial cardiomyocytes to model atrial fibrillation in a dish
    Human iPSC-derived atrial cardiomyocytes to model atrial fibrillation in a dish
    国内基金
    海外基金
    Chinese Journal of Integrative Medicine
    • 批准号:
      81224004
    • 项目类别:
      专项基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2012
    • 负责人:
      徐浩
    • 依托单位: